abstract |
An object of the present invention is to provide a novel polymorph of the vasopressin V 2 agonists. Novel of 1- (2-methyl-4- (2,3,4,5-tetrahydro-1-benzazepin-1-ylcarbonyl) benzylcarbamoyl) -L-proline-N, N-dimethylamide Polymorphs, pharmaceutical compositions containing them and their use in therapy. [Selection figure] None |